Optimum Strategic Communications

Optimum Strategic Communications company information, Employees & Contact Information

Optimum is an international strategic communications firm specialising in investor relations, corporate and financial communications. Our team of healthcare specialists, based in London and New York, have worked together for many years. Our first-hand experience of analysing, investing and writing about healthcare companies uniquely positions us when advising our clients on building a compelling investment story. Subscribe to our Optimum Perspectives Podcast, where we host industry leaders, and highlight the latest innovation and developments in life sciences. Listen here now: https://www.optimumcomms.com/podcast/

Company Details

Employees
21
Founded
-
Address
8 Devonshire Square, London,london Ec2m 4yp,united Kingdom
Industry
Public Relations And Communications Services
NAICS
Public Relations Agencies
HQ
London, London
Looking for a particular Optimum Strategic Communications employee's phone or email?

Optimum Strategic Communications Questions

News

55 North Announces First Close for Record €300M Quantum Technology Fund - Business Wire

55 North Announces First Close for Record €300M Quantum Technology Fund Business Wire

Biocomposites announces new approval for STIMULAN® to treat bacterial infection - Ortho Spine News

Biocomposites announces new approval for STIMULAN® to treat bacterial infection Ortho Spine News

Sofinnova Welcomes Agnès Pauquet as Head of Human Resources - Business Wire

Sofinnova Welcomes Agnès Pauquet as Head of Human Resources Business Wire

Sofinnova Partners Exceeds Target With €165M Biotech Acceleration Fund, Europe’s Largest, With Strong Pharma Support - Business Wire

Sofinnova Partners Exceeds Target With €165M Biotech Acceleration Fund, Europe’s Largest, With Strong Pharma Support Business Wire

Sofinnova Partners Raises €1.2 Billion to Fuel the Next Wave of Life Sciences Innovation - Business Wire

Sofinnova Partners Raises €1.2 Billion to Fuel the Next Wave of Life Sciences Innovation Business Wire

Noema Pharma extends Series B financing round, closing at CHF 130 Million ($147 Million) - Business Wire

Noema Pharma extends Series B financing round, closing at CHF 130 Million ($147 Million) Business Wire

NorthStar Medical Radioisotopes and Ariceum Therapeutics Announce Supply Agreement for Therapeutic Radioisotope Actinium-225 (Ac-225) - Business Wire

NorthStar Medical Radioisotopes and Ariceum Therapeutics Announce Supply Agreement for Therapeutic Radioisotope Actinium-225 (Ac-225) Business Wire

BrightHeart Unveils Breakthrough AI Results at the Society for Maternal-Fetal Medicine (SMFM) 2025 Pregnancy Meeting, Revolutionizing Prenatal Care - Business Wire

BrightHeart Unveils Breakthrough AI Results at the Society for Maternal-Fetal Medicine (SMFM) 2025 Pregnancy Meeting, Revolutionizing Prenatal Care Business Wire

Incyte Announces Agreement to Acquire Medicxi-backed Villaris Therapeutics and Auremolimab (VM6), an Anti-IL-15Rβ Monoclonal Antibody - Business Wire

Incyte Announces Agreement to Acquire Medicxi-backed Villaris Therapeutics and Auremolimab (VM6), an Anti-IL-15Rβ Monoclonal Antibody Business Wire

Top Optimum Strategic Communications Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant